Page last updated: 2024-08-17

physostigmine and Growth Disorders

physostigmine has been researched along with Growth Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bach, LA; Berkovic, SF; Fedi, M; Reutens, DC; Scheffer, IE; Willoughby, JO	1

Other Studies

1 other study(ies) available for physostigmine and Growth Disorders

Article	Year
Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone release. The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:2 Topics: Adolescent; Adult; Aged; Body Height; Body Mass Index; Cholinesterase Inhibitors; Female; Follicle Stimulating Hormone; Growth Disorders; Human Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Physostigmine; Point Mutation; Prolactin; Receptors, Nicotinic; Thyrotropin; Thyroxine	2008

Article

Year

Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone release.

The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:2

Topics: Adolescent; Adult; Aged; Body Height; Body Mass Index; Cholinesterase Inhibitors; Female; Follicle Stimulating Hormone; Growth Disorders; Human Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Physostigmine; Point Mutation; Prolactin; Receptors, Nicotinic; Thyrotropin; Thyroxine

2008